← Back to Search

Intervention group for Opioid Use Disorder

N/A
Waitlist Available
Led By Mark Sullivan, MD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

Study Summary

This trial will help 100 people taper off opioids after being discharged from the hospital following trauma. A physician assistant will work with the patients' primary care physicians to help manage their pain and taper them off opioids. The goal is to improve pain and opioid outcomes for these patients and support the primary care physicians who care for them.

Eligible Conditions
  • Opioid Use Disorder
  • Trauma
  • Postoperative Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary opioid outcome: percent of patients at or below their pre-trauma opioid daily dose
Primary pain outcome: Pain, Enjoyment, General Activity (PEG)
Secondary outcome measures
Illicit drug use
PROMIS-29 health status
Past-month cannabis use
+2 more
Other outcome measures
Acceptability of Intervention Measure (AIM)
Adoption
Feasibility
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
Subjects will receive standard trauma discharge plan and no more than a 2-week supply of opioids. Subjects will complete surveys at baseline, 12-week, and 24-week post hospital discharge. In addition, subjects will receive: A face-to-face meeting prior to discharge where the PA will discuss with the subject their individualized pain management plan and individualized opioid taper plan. PA will contact subject on the phone within the first week after hospital discharge to ensure subject plans to follow up with PCP and to troubleshoot any subject concerns related to pain management.
Group II: Control groupActive Control1 Intervention
Subjects will receive standard trauma discharge plan and no more than a 2-week supply of opioids. Subjects will complete surveys at baseline, 12-week, and 24-week post hospital discharge.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,741 Previous Clinical Trials
1,847,666 Total Patients Enrolled
Centers for Disease Control and PreventionFED
875 Previous Clinical Trials
22,477,302 Total Patients Enrolled
Harborview Injury Prevention and Research CenterOTHER
11 Previous Clinical Trials
14,409 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Collaborative Opioid Taper After Trauma: Preventing Opioid Misuse and Opioid Use Disorder
Mark Sullivan 2020. "Collaborative Opioid Taper After Trauma: Preventing Opioid Misuse and Opioid Use Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04275258.
~21 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top